Institutional Ownership
Drugs Made In Amer Acqutn Co
CUSIP G2847J112RIGHT 10/15/2029Q1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
35
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Polar Asset Management Partners Inc. | 1.90M | $114.0K |
| 2 | Hudson Bay Capital Management LP | 1.70M | $93.8K |
| 3 | Highbridge Capital Management LLC | 1.04M | $62.6K |
| 4 | Mangrove Partners Im, LLC | 850.0K | $51.3K |
| 5 | Linden Advisors LP | 850.0K | $48.9K |
| 6 | Clear Street Group Inc. | 711.9K | $43.0K |
| 7 | Boothbay Fund Management, LLC | 695.2K | $42.0K |
| 8 | Wolverine Asset Management LLC | 693.1K | $41.9K |
| 9 | Toronto Dominion Bank | 690.0K | $41.4K |
| 10 | Lmr Partners LLP | 500.0K | $30.2K |